Tom Huijbers

Tom Huijbers is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as the Executive Vice President of Regulatory at GENFIT since March 2023, Tom also holds the position of Head of Regulatory Affairs at Harm Reduction Therapeutics since May 2020. Previous roles include regulatory consultancy at B. More, Inc. and Ceruvia Lifesciences, as well as independent consultancy at Pinney Associates, Inc. Tom has a significant background with Grünenthal Group, where responsibilities spanned from VP, Head of Development Strategy and Intelligence to various roles in regulatory affairs over a 15-year tenure. Early career positions include roles at J&JPRD and Janssen Research Foundation. Educational qualifications include participation in the Grünenthal INSEAD Leadership Development Programme at INSEAD and advanced studies in business management and medicinal chemistry from esteemed institutions.